Clal Insurance Enterprises Holdings LTD has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $13.1 Billion distributed in 215 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Index Fds S&P 500 ETF with a value of $1.8B, Invesco Exchange Traded Fd Tr with a value of $959M, Spdr S&P 500 ETF Trust with a value of $872M, Teva Pharmaceutical Industries LTD with a value of $633M, and Elbit Systems LTD with a value of $586M.

Examining the 13F form we can see an increase of $3.44B in the current position value, from $9.68B to 13.1B.

Clal Insurance Enterprises Holdings LTD is based out at Tel Aviv, L3

Below you can find more details about Clal Insurance Enterprises Holdings LTD portfolio as well as his latest detailed transactions.

Portfolio value $13.1 Billion
ETFs: $6.39 Billion
Technology: $2.9 Billion
Healthcare: $801 Million
Industrials: $705 Million
Utilities: $390 Million
Communication Services: $324 Million
Basic Materials: $296 Million
Consumer Cyclical: $249 Million
Other: $218 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 215
  • Current Value $13.1 Billion
  • Prior Value $9.68 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 36 stocks
  • Additional Purchases 55 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 90 stocks
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.